RECURRENT BRAIN NEOPLASM
Clinical trials for RECURRENT BRAIN NEOPLASM explained in plain language.
Never miss a new study
Get alerted when new RECURRENT BRAIN NEOPLASM trials appear
Sign up with your email to follow new studies for RECURRENT BRAIN NEOPLASM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could an immune booster help kids fight deadly brain cancer?
Disease control OngoingThis early-stage trial is testing the safety and potential benefit of pembrolizumab, an immunotherapy drug, in 71 children whose brain tumors (like DIPG, high-grade gliomas, or medulloblastoma) have come back or not responded to standard treatments. The drug works by helping the …
Matched conditions: RECURRENT BRAIN NEOPLASM
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
New drug cocktail targets Hard-to-Treat cancers in kids and young adults
Disease control OngoingThis early-phase trial tests a combination of three drugs (dasatinib, temsirolimus, and cyclophosphamide) in children and young adults with advanced solid tumors that have come back or not responded to standard treatment. The main goals are to find the safest dose and understand …
Matched conditions: RECURRENT BRAIN NEOPLASM
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Second radiation for brain tumors: a safer approach?
Symptom relief OngoingThis pilot trial is testing how to safely give a second round of radiation to people whose brain tumors have returned after previous radiation. The study uses special dose limits and the drug bevacizumab to try to reduce brain damage. Forty participants are being followed to see …
Matched conditions: RECURRENT BRAIN NEOPLASM
Phase: NA • Sponsor: M.D. Anderson Cancer Center • Aim: Symptom relief
Last updated Jun 27, 2026 08:08 UTC